Abstract:Xia Sheng, Ting Li, Yi Hu, Cheng-Shun Xiong, Ling Hu Department of Endocrine, The First Hospital of NanChang City, Nanchang, Jiangxi, 330008, People's Republic of China Correspondence: Ling Hu, Email Objective: To discuss the relationship between time in range (TIR) which is deprived of the FGMS and the risk of diabetic vascular complications and to provide a theoretical foundation for the clinical application of TIR and other FGMS-deprived indexes. Methods: Patients with T2DM who wore the FGMS sensor continuously were enrolled. Relevant indexes such as TIR, time below range (TBR), time above range (TAR), a standard deviation of blood glucose (SDBG), coefficient of variation of blood glucose (CV), and mean amplitude of glycemic excursion (MAGE) generated by the FGMS were recorded, and the risk of diabetic vascular complications were followed up for one year. The TIR was measured by continuous glucose monitoring at baseline, and patients were grouped according to TIR every 20%. Finally, the Cox proportional hazards regression model was used to estimate the association of different levels of TIR with different rates of diabetic vascular complications. Results: TIR was negatively correlated with HbA1C, CV, SDBG, and amplitude of glycemic excursion (MV), wherein, the lower the TIR, the higher the HbA1C, CV, SDBG, and MV. TIR in the diabetic microvascular complication was significantly lower than that in the non-microvascular complication group, and the difference was statistically significant. TIR 10.0 mmol/L) and time below range (TBR) (<3.9 mmol/L) should be analyzed in blood glucose assessment. 4 TIR combined with indexes such as TAR and TBR can better reflect and help control the changes in blood glucose of individuals. The application value of the glucose index derived from this emerging CGM technology in the Chinese population remains unexplored due to the lack of clinical experience with FGMS, as it has not been in the market for a long time. 5 In addition, correlation studies between TIR and diabetes-related chronic complications are scarce. This study aims to examine the relationship between blood glucose-related indexes automatically generated by the FGMS and diabetes-related chronic complications to provide evidence for TIR which is a reference index for clinical blood glucose regulation and a predictor of the risk for diabetic complications in multiple aspects. A total of 545 patients with T2DM who wore the flash glucose monitoring sensor (for 7–14 days) during their stay at the hospital between October 2020 and October 2021 were enrolled, and a retrospective study was conducted. Clinical data were obtained from the clinical electronic medical record database and the FGM companion software. This s -Abstract Truncated-

Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complications

Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?

Impact of short-term glycemic variability on risk of all-cause mortality in type 2 diabetes patients with well-controlled glucose profile by continuous glucose monitoring: A prospective cohort study

Glycemic Variability Evaluated by Continuous Glucose Monitoring System is Associated with the 10-Y Cardiovascular Risk of Diabetic Patients with Well-Controlled HbA1c.

Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring

Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes

Glycemic variability: adverse clinical outcomes and how to improve it?

Establishment Of Normal Reference Ranges For Glycemic Variability In Chinese Subjects Using Continuous Glucose Monitoring

Potential Benefits of Continuous Glucose Monitoring for Predicting Vascular Outcomes in Type 2 Diabetes: A Rapid Review of Primary Research

Correlation Between Blood Glucose Indexes Generated by the Flash Glucose Monitoring System and Diabetic Vascular Complications

Glycemic Variability Modifies the Relationship Between Time in Range and Hemoglobin A1c Estimated from Continuous Glucose Monitoring: A Preliminary Study

Long-term glycemic variability and risk of adverse health outcomes in patients with diabetes: A systematic review and meta-analysis of cohort studies

Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis

The Relation of Diabetes Complications to a New Interpretation of Glycaemic Variability from Continuous Glucose Monitoring in People with Type 1 Diabetes

Association of long-term visit-to-visit glycemic variability with risk of adverse clinical outcomes in diabetic patients with heart failure with preserved ejection fraction

Clinical implications and pharmacological considerations of glycemic variability in patients with type 2 diabetes mellitus

Association of Various Glycemic Variability Indices and Vascular Outcomes in Type-2 Diabetes Patients

Diabetic peripheral neuropathy and glycemic variability assessed by continuous glucose monitoring: A systematic review and meta-analysis

Impact of acute glycemic variability on short-term outcomes in patients with ST-segment elevation myocardial infarction: a multicenter population-based study

Implications of glycemic risk index across different levels of glycated hemoglobin (HbA1c) in type 1 diabetes

Association of HbA1c with All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes